Intervention

Ertugliflozin 10 mg

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions2
Lead sponsors shown2

Clinical trials

5 shown
Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial InfarctionNCT07621380 · 2026-07-01
NOT_YET_RECRUITING
Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)NCT02099110 · 2014-04-22
COMPLETED
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)NCT01999218 · 2013-12-16
COMPLETED
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)NCT01986855 · 2013-12-02
COMPLETED
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)NCT01958671 · 2013-10-09
COMPLETED

Trial status mix

COMPLETED4
NOT_YET_RECRUITING1

Phase mix

PHASE34
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.